Clinical and laboratory presentations of Janus Kinase II-positive patients in Saudi population
Introduction: Janus Kinase II (JAK-II) mutation has a pivotal role in the pathogenesis of the myeloproliferative neoplasms (MPN) and has been shown to be involved in thrombotic complications of these diseases. However, there are limited data regarding clinic-biological features and cytogenetic abnor...
Main Authors: | H Malhan, H Alzahrani, Ghada M Elgohary, T Owaidah, M Aslam, Said Yousuf Mohamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2014;volume=5;issue=4;spage=133;epage=140;aulast=Malhan |
Similar Items
-
Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012-06-01) -
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
by: Angela Liu, et al.
Published: (2022-12-01) -
Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
by: Roelof H. Bekendam, et al.
Published: (2023-06-01) -
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
by: Tarinee Rungjirajittranon, et al.
Published: (2019-02-01) -
New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
by: Domenico Penna
Published: (2021-10-01)